April 28th, 2011
A mother was involved in a ten-hour stand-off with a police SWAT team after refusing to give her child some medication.
Maryanne Godboldo, from Detroit, was accused of medically neglecting her 13-year-old daughter Ariana by not administering her with an anti-psychotic drug.
Staff from the Child Protective Services, accompanied by police, turned up at Godboldo’s home to take her child into state care.
A SWAT team then descended on the 56-year-old woman’s house with a tank and automatic rifles after she was accused of firing a gun at police officers.
After a ten-hour stand-off, which resulted in the mother giving herself up, Ariana was taken into protective custody.
The girl had been home-schooled by her mother but wanted to start going to a regular school, which required her to take a number of immunisations, reports Prisonplanet.com.
The girl then suffered adverse reactions to these shots and her mother was told to put her on a prescribed pyschotropic drug.
‘She began acting out of character, being irritated, having facial grimaces that have been associated with immunisations,’ the child’s aunt, Penny Godboldo, told the Detroit News.
The mother at first took the advice of doctors and gave Ariana the medication, Risperdal, but stopped after she said it was making her daughter’s condition worse.
Risperdal is an anti-psychotic medication which works by changing the effects of chemicals in the brain.
It is used to treat, among other things, schizophrenia, as well as the symptoms of bipolar disorder and autism.
‘Child Protective Services was trying to force her child to take a dangerous medication, Risperdal, against her will,’ said the Godboldo family lawyer.
Maryanne Godboldo is now facing criminal charges including firing a weapon in her house and resisting a police officer.
Her bail has been set at $500,000.
‘We’re hoping that Ariana is returned home, this whole matter is released, because we don’t think that the mother has done anything at all,’ attorney Wanda Evans told My FOX Detroit.
Ariana remains in protective custody, at the Hawthorne Center in Northville.
Officials have said they have not medicated the girl since she has been in their care.
April 21st, 2011
By: Sheila Marikar
For months, Catherine Zeta-Jones played the part of the devoted wife as her husband, actor Michael Douglas, sought treatment for throat cancer. Now, it seems all wasn’t well in her world.
Today, Zeta-Jones’ publicist revealed that the actress recently sought treatment for bipolar disorder.
“After dealing with the stress of the past year, Catherine made the decision to check in to a mental health facility for a brief stay to treat her Bipolar II Disorder,” her publicist said in a statement. “She’s feeling great and looking forward to starting work this week this week on her two upcoming films.”
Bipolar disorder is also called manic-depressive illness. The disorder is most known for the unusual shifts in mood and energy that those with it experience. Sufferers can go through what is known as a manic episode — an overly excited or joyful state — or a depressive episode — a state of unusual sadness or hopelessness.
Bipolar II disorder is not as severe as bipolar I. According to the National Institute of Mental Health, while those with bipolar I typically experience mania and intense mood episodes that can last at least seven days and may require hospitalization, bipolar II usually results in less intense depressive episodes.
While bipolar disorder often develops in a person’s late teens or early adult years, it has been known to develop later on in life as well.
Zeta-Jones, 41, was outspoken about her anger after Douglas, 66, was diagnosed with throat cancer in August 2010.
“It makes me furious they didn’t detect it earlier,” Zeta-Jones told People magazine. “He sought every option and nothing was found.”
Douglas’ cancer wasn’t the only stress in the couple’s life. Last year, Douglas’ ex-wife took him to court seeking a some of his profits from his “Wall Street” sequel, which was released in 2010 but was based on the iconic film that he made while they were married, which she said entitled her to a share.
Zeta-Jones reportedly turned down roles to be by Douglas’ side through his legal and physical battles. In January, Douglas noted that his cancer fight drew him and Zeta-Jones closer.
“One thing that all cancer survivors talk about is a new depth of feeling that you have for loved ones,” he said while receiving an award at the Palm Springs Film Festival. Zeta-Jones was at the festival with him.
“It’s made us even closer,” he added, “and certainly there’s a depth of emotion and an appreciation of your daily life that you didn’t have before.”
Zeta-Jones and Douglas married in 2000. They have two children together, Dylan Michael Douglas and Carys Zeta Douglas.
January 5th, 2010
The Village Voice
By: Jason Parham
In this week’s cover story, writer Keegan Hamilton investigates the controversy surrounding ibogaine, the experimental hallucinogen drug that has helped kick meth and heroin addictions.
Ibogaine is illegal, even though its power to cure addicts has been proven. Hamilton’s story describes the many reasons the medical establishment and the government are wary of Ibogaine, despite its benefits, but one of them really stood out:
Because Ibogaine is an outright cure, drug companies want nothing to do with it.
Martin Kuehne, a chemist at the University of Vermont, is quoted in the story, saying, “Pharmaceutical companies don’t like cures. Really, they don’t — that’s the sad thing. They like treatment. Something for cholesterol or high blood pressure that you take for years and years, every day. That’s where the profit is.”
When we read that, a light went on. The worst thing for a drug company is a pill you take that completely cures you of your ailment with one dose, right? Where’s the money in that?
So, with that in mind, we thought we’d test Kuehne’s theory, and look at the five most profitable drugs in the United States.
Guess what they all have one in common? They never cure you.
1) Lipitor (2009 gross revenue: $7.5 billion): Designed to lower cholesterol, Lipitor uses statins to decrease LDL cholesterol and triglyceride levels and increase HDL cholesterol levels. Studies indicate that high cholesterol increases one’s chance for heart disease, the leading health problem in the U.S.
2) Nexium (2009 gross revenue: $6.3 billion): This well-marketed drug decreases the amount of acid produced in the stomach, but it’s not an instant cure for heartburn.
3) Plavix (2009 gross revenue: $5.6 billion): Nobody likes a nasty blood clot, and this drug prevents that from happening, particularly after a stroke or a heart attack. The downside: Plavix increases your chances of small-injury bleeds and, if drinking alcohol, heightens your risk of stomach and intestinal bleeds.
4) Advair Diskus (2009 gross revenue: $4.7 billion): For asthma sufferers, a twice-daily inhaler to reduce the swelling in your respiratory system. Helps keep attacks from being more severe.
5) Seroquel (2009 Gross: $4.2 billion): Rounding out our top 5 is Seroquel, an anti-psychotic drug that treats schizophrenia, severe depression, and bipolar disorder by altering chemical activity in the brain.
December 28th, 2010
The Wall Street Journal
By: Anna Wilde Mathews
Gage Martindale, who is 8 years old, has been taking a blood-pressure drug since he was a toddler. “I want to be healthy, and I don’t want things in my heart to go wrong,” he says.
And, of course, his mom is always there to check Gage’s blood pressure regularly with a home monitor, and to make sure the second-grader doesn’t skip a dose of his once-a-day enalapril.
These days, the medicine cabinet is truly a family affair. More than a quarter of U.S. kids and teens are taking a medication on a chronic basis, according to Medco Health Solutions Inc., the biggest U.S. pharmacy-benefit manager with around 65 million members. Nearly 7% are on two or more such drugs, based on the company’s database figures for 2009.
Doctors and parents warn that prescribing medications to children can be problematic. There is limited research available about many drugs’ effects in kids. And health-care providers and families need to be vigilant to assess the medicines’ impact, both intended and not. Although the effects of some medications, like cholesterol-lowering statins, have been extensively researched in adults, the consequences of using such drugs for the bulk of a patient’s lifespan are little understood.
Many medications kids take on a regular basis are well known, including treatments for asthma and attention-deficit hyperactivity disorder.
But children and teens are also taking a wide variety of other medications once considered only to be for adults, from statins to diabetes pills and sleep drugs, according to figures provided to The Wall Street Journal by IMS Health, a research firm. Prescriptions for antihypertensives in people age 19 and younger could hit 5.5 million this year if the trend though September continues, according to IMS. That would be up 17% from 2007, the earliest year available.
Researchers attribute the wide usage in part to doctors and parents becoming more aware of drugs as an option for kids. Unhealthy diets and lack of exercise among children, which lead to too much weight gain and obesity, also fuel the use of some treatments, such as those for hypertension. And some conditions are likely caught and treated earlier as screening and diagnosis efforts improve.
Gage, who isn’t overweight, has been on hypertension drugs since he had surgery to fix a heart defect as a toddler, says his mother, Stefanie Martindale, a Conway, Ark., marketing-company manager.
Most medications that could be prescribed to children on a chronic basis haven’t been tested specifically in kids, says Danny Benjamin, a Duke University pediatrics professor. And older drugs rarely get examined, since pharmaceutical firms have little incentive to test medicines once they are no longer under patent protection.
Still, a growing number of studies have been done under a Food and Drug Administration program that rewards drug companies for testing medications in children. In more than a third of these studies, there have been surprising side effects, or results that suggested a smaller or larger dose was needed than had been expected, Dr. Benjamin says. Those findings underscore that children’s reactions to medicines can be very different than those of adults. Long-term effects of drugs in kids are almost never known, since pediatric studies, like those in adults, tend to be relatively short.
“We know we’re making errors in dosing and safety,” says Dr. Benjamin, who is leading a new National Institutes of Health initiative to study drugs in children. He suggests that parents should do as much research as they can to understand the evidence for the medicine, confirm the diagnosis, and identify side effects. Among the places to check: drug labels and other resources on the FDA’s website, published research at www.pubmed.gov, and clinical guidelines from groups like the American Academy of Pediatrics.
When a child psychiatrist diagnosed their then 8-year-old daughter with bipolar disorder four years ago, Ken and Joy Lewis, of Chapel Hill, N.C., sought a second opinion from another child psychiatrist.
They also worked with a psychologist. Dr. Lewis, who leads a company that does early-stage drug studies, reads all the available research on each medication suggested for the girl, now 12, who has taken antipsychotics and other psychiatric medications including Risperdal and Haldol.
“If your child has a chronic problem, then you have to invest the time as a parent,” he says.
Parents and doctors also say nondrug alternatives should be explored where possible. Tom Wells, a professor of pediatrics at the University of Arkansas for Medical Sciences who sees patients at Arkansas Children’s Hospital in Little Rock, frequently pushes diet and exercise changes before drugs for hypertensive kids. “Obesity is really the biggest cause I see for high blood pressure in adolescents,” he says. But only about 10% of families adhere to his diet and exercise recommendations, he says.
Beverly Pizzano, a psychologist who lives in Palm Harbor, Fla., spent years struggling with behavioral therapies for her son Steven, 10, who showed symptoms of ADHD at a young age. She worked with a counselor on a system of rewards for good behavior, and even had a research team watch him and suggest interventions. But she turned to medications after he struggled in kindergarten. “We tried everything before I would get to that,” she says.
After a drug is prescribed, children must be closely monitored, doctors say. They may not recognize or communicate a possible side effect, or whether their symptoms are improving. They also don’t always follow prescription instructions.
Robert Lemanske, a professor at the University of Wisconsin in Madison, says patients at his pediatric asthma clinic are checked regularly for side effects such as slowed rates of growth. He quizzes parents and young patients on details like where they keep their inhalers to make sure they’re taking their prescribed medicine.
Nichole Ramsey, a preschool teacher whose 9-year-old son Antwone is a patient at the clinic, watches her son’s basketball practices so she can head off any wheezing or other symptoms. She also makes sure she’s around when he gets his regular Advair dose. If Antwone stays at a friend’s house overnight, she asks the parents to watch that he takes steps like rinsing out his mouth to avoid a fungal infection that can be a side effect of the inhaled drug.
“You’re still the best monitor of what’s going on with them,” she says of a parent’s role.
Ms. Ramsey is particularly concerned about Advair, which has been tied to rare instances of asthma-related death, but says it works better than a previous drug he was using. Before he started the medications, Antwone was hospitalized several times for asthma attacks.
As children’s bodies change and grow, they often need different drugs or doses, says Greg Kearns, chairman of medical research at Children’s Mercy Hospital in Kansas City, Mo.
Jennifer Flory, a homemaker in Baldwin City, Kan., says that after her daughter Cassandra, now 16, started taking a higher dose of the asthma drug Singulair a few years ago, she became more moody and sad. Ms. Flory didn’t connect the change to the drug, but when she eventually mentioned it to a nurse practitioner at the girl’s asthma clinic, the nurse suggested stopping Singulair, which currently has a precaution in its label about possible psychiatric side effects. Cassandra, who continued taking Advair, became far more cheerful and didn’t have any increase in asthma symptoms, Ms. Flory says.
A spokesman for Merck & Co., which makes Singulair, said in a statement that the company is “confident in the efficacy and safety of Singulair,” which is “an important treatment option for appropriate patients.”
December 7th, 2010
By: David Gutierrez
Questions are being raised over whether a widely prescribed anti-psychotic drug may be contributing to the deaths of traumatized U.S. war veterans.
Among those who recently died while taking AstraZeneca’s blockbuster drug Seroquel are Marine corporals Andrew White and Chad Oligschlaeger. Both were being given multiple drugs, including Seroquel, for the treatment of post-traumatic stress disorder (PTSD). Both died in their sleep.
Before his death, White was being given more than double the maximum recommended Seroquel dose for patients suffering from schizophrenia.
“He was told if he had trouble sleeping he could take another pill,” said his father, Stan White.
Seroquel is the United States’ fifth-best-selling drug, and one of the top prescribed drugs by the Veteran Affairs Department. Since the start of the Afghanistan war, government spending on the drug has increased more than 770 percent to $8.6 million per year. Yet in the same time period, the number of patients being treated by the department increased by only 34 percent.
The drug is approved only for the treatment of schizophrenia, bipolar disorder and depression, yet it is commonly given to vets for insomnia and other PTSD symptoms. According to The New York Times Guide to Essential Knowledge, other side effects “may include dry mouth, blurred vision, and tardive dyskinesia, typified by involuntary movements of the lips, mouth, and tongue.” Other proven side effects include weight gain and diabetes, while new research suggests that the drug may also cause sudden heart failure.
Medical examiners concluded that both White and Oligschlaeger died of “multiple drug toxicity” caused by a deadly interaction between the different drugs they were taking; such deaths are not recorded as caused by any single drug. Yet family and advocates of vets are becoming increasingly concerned that Seroquel may bear a large part of the blame for such deaths, and are calling for a reevaluation of prescribing practices for the drug.
“Right now, I’m so angry, and I believe someone needs to be held accountable,” said Oligschlaeger’s mother, Julie Oligschlaeger. “The protocol absolutely has to change.”
August 31, 2010
by David Gutierrez
Popular anti-seizure drugs may seriously increase a patient’s risk of suicide and violent death, according to a study conducted by researchers from Brigham and Women’s Hospital and Harvard Medical School, and published in the Journal of the American Medical Association.
The drugs, known as anticonvulsants, were initially designed for the treatment of epilepsy but are now widely prescribed “off-label” for conditions such as bipolar disorder, migraine headaches and pain.
“We all know the range of uses of these medications is very, very wide,” researcher Elisabetta Patorno said.
The researchers examined the prescription and medical records of more than 300,000 people above the age of 14 who had been prescribed an anticonvulsant for the first time between July 2001 and December 2006.
All of the drugs, they found, significantly increased a patient’s risk of attempted or successful suicide, as well as violent death by other causes. During the course of the study, there were 801 attempted suicides, 26 successful suicides and 41 violent deaths.
“We found increased risk for suicidal acts beginning within the first 14 days after treatment initiation, opening the possibility that anticonvulsant medications could induce behavioral effects prior to the achievement of their full therapeutic effectiveness,” the researchers wrote.
Based on prior studies, the FDA ruled in 2008 that all anticonvulsants must carry labels warning that they double the risk of suicidal thoughts and actions. These older studies had not been able to determine if any drugs posed higher risks than others, however.
In the current study, researchers compared the rates of suicides and violent deaths among users of topiramate (sold generically and also marketed as Topamax), gabapentin (marketed as Neurontin), lamotrigine (marketed as Lamictal), oxcarbazepine (marketed as Trileptal), tiagabine (marketed as Gabitril) and valproate (marketed as Depakine and Epilim). They found that the risk was lowest in topiramate, and roughly equal in the five other drugs.
November 23, 2009
By David Gutierrez
Contrary to the impression promoted by the psychiatric and drug industries, psychiatric drugs do not work by correcting a chemical imbalance in the brain, Joanna Moncrieff of University College London wrote recently in an opinion piece for the BBC. Instead, such drugs merely put people into “drug-induced states” that make it harder for them to experience the symptoms of their illness.
“Magazines, newspapers, patients’ organizations and Internet sites have all publicized the idea that conditions like depression, anxiety, schizophrenia and bipolar disorder can be treated by drugs that help to rectify an underlying brain problem … just like a diabetic needs to take insulin,” Moncrieff writes. “The trouble is, there is little justification for this view.”
Moncrieff notes that prior to the 1950s, mental health workers largely saw antidepressants as psychoactive drugs, primarily sedatives, that eased the symptoms of depression without addressing the underlying cause – much as over-the-counter cold drugs may stop a runny nose without affecting the cold virus. This view was eventually replaced by the idea that depression, schizophrenia, anxiety and other mental health conditions result from chemical imbalances in the brain, imbalances that can be corrected by the right “magic bullet.”
“However, this transformation was not based on any compelling evidence,” she says.
Moncrieff holds to the older view, that “drugs used in psychiatry are psychoactive drugs, like alcohol and cannabis. They affect everyone, regardless of whether they have a mental disorder or not.”
Antipsychotics, she notes, mute people’s emotions and thoughts, which can reduce the effects of psychosis as a side effect. Anti-anxiety drugs are central-nervous system depressants, like alcohol.
“If you told people that we have no idea what is going on in their brain, but that they could take a drug that would make them feel different and might help to suppress their thoughts and feelings, then many people might choose to avoid taking drugs if they could,” she writes. “People need to make up their own minds.”
October 28, 2009
By David Gutierrez
Internal documents acquired as part of a series of lawsuits show that pharmaceutical giant AstraZeneca planned as early as 2001 to market its antipsychotic drug Seroquel for uses not approved by the FDA.
Under U.S. law, drug makers are prohibited for marketing their drug for any use not approved by the FDA. Doctors are still permitted to prescribe drugs, however, for any use they wish.
Seroquel (generic name quetiapine) was approved for the treatment of psychotic disorders in adults in 1997. In 2001, the FDA extended this approval to cover schizophrenia. In 2004, it was approved for use of bipolar mania, and in 2006 it was approved for bipolar disorder.
Yet AstraZeneca is now the defendant in thousands of lawsuits claiming, among other allegations, that the company actively marketed the drug for use in children and adolescents, and also sought to market it as a treatment for dementia in the elderly.
In some of the retrieved documents, AstraZeneca employees and employees of a consulting firm hired by the company reference plans to “broaden Seroquel use on- and off-label,” specifically mentioning adolescents and people suffering from Alzheimer’s or Parkinson’s disease. Areas where the company could promote this use are listed, including sales calls and meetings with medical professionals or patient advocacy groups.
In a 2001 public relations plan, the company says that it seeks to “encourage and support [Seroquel] use outside schizophrenia into a broad range of other patient populations including bipolar disorder and the elderly.” The document calls for “aggressive market penetration” of the drug in the demographics of adolescents, the elderly and bipolar patients.
This came five years before the drug’s approval as a treatment for bipolar disorder. To date, the drug has never been approved for use in children, adolescents or patients with dementia or Parkinson’s disease.
AstraZeneca has applied for FDA approval to use Seroquel as a treatment for adolescent schizophrenia and acute bipolar mania in children and adolescents. No antipsychotic drugs have yet been approved for use in children, as there is nearly no evidence on their safety or effectiveness in that population.
The Seroquel lawsuits are only one of a number of recent scandals in which pharmaceutical giants have been accused of illegally promoting off-label drug use. Eli Lilly recently agreed to pay a $1.42 billion settlement to end charges that it promoted its antipsychotic Zyprexa (olanzapine) off-label.
October 28, 2009
By Nathan Seppa
Many young children and adolescents taking drugs for severe psychiatric problems gain substantial weight and, in some cases, show increased levels of LDL cholesterol and triglycerides in their blood, researchers report in the Oct. 28 Journal of the American Medical Association.
Although the data from this study need to be replicated over a longer time frame, the findings nonetheless raise worrisome questions about anti-psychotic drugs that often benefit children who have schizophrenia, autism, tics, severe bipolar disorder or aggressive behavior.
“We are between a rock and a hard place here,” says study coauthor Christoph Correll, a psychiatrist at the Zucker Hillside Hospital in Glen Oaks, N.Y. These mental disorders are severe and can lead to suicide or to educational problems and emotional scars, he says. On the other hand, weight gain during youth predisposes an individual to chronic health problems later in life, he says.
Weight gain has been noticed before in children and adolescents taking commonly prescribed drugs for severe psychiatric problems. But studies seeking to link that weight gain to the medications were often muddied because patients had taken one of the drugs beforehand at some point — and may have already put on weight from it or reset their body metabolism to adjust to the drug somehow.
In the new study, Correll and his colleagues monitored 272 children, ages 4 to 19, between 2001 and 2007. Of these, 257 were getting psychotropics for severe problems for the first time, and 15 others refused the drugs but agreed to be seen by a doctor. The drugs were olanzapine (Zyprexa), quetiapine (Seroquel), risperidone (Risperdal) or aripiprazole (Abilify). Restricting the study to first-timers eliminated problems encountered in earlier studies.
After a median follow-up period of nearly 11 weeks, these patients had gained 10 to 19 pounds on average, depending on the drug. Kids on Zyprexa gained the most, on average, while those taking Abilify gained the least. The 15 patients who had refused drug treatment gained less than one pound on average during the monitoring period.
The pace of weight gain seems to level off over time, Correll says, but further study will be needed to clarify that trend.
“This is a really good study of relatively short-term effects,” says Christopher Varley, a child psychiatrist at the University of Washington School of Medicine and Seattle Children’s Hospital. But longer-term data are needed, he says, “because you never really treat a kid with one of these conditions for only 12 weeks — it’s more like six to nine months or a year or two.”
FDA Approval of Antipsychotics for Children Mirrors Bayer, AMA Approvals of Heroin as Cough Medicine for Children
June 11, 2009
by Mike Adams
(NaturalNews) Today an FDA advisory panel approved the prescribing of powerful mind-altering chemicals for children. Seroquel, Zyprexa and Goedon have now been approved by the advisory panel to be prescribed to children as young as 10 years old to treat a fictitious disease invented by psychiatrists and given the name “bipolar disorder.” (There is no such thing as a bipolar disorder disease. It is merely a name assigned to children demonstrating the predictable side effects of correctable dietary imbalances.)
In light of this disturbing decision, it is instructive to remember the history of pharmaceutical medicine and children. One hundred and ten years ago, Bayer marketed heroin to children as a non-addictive alternative to morphine. Did I say “non-addictive?” Yes, it’s right from the company’s own marketing materials. It just goes to show you that drug companies have been lying to the public (and poisoning the children) for well over one hundred years.
Much like the FDA’s present-day endorsement of antipsychotic drugs for children, the American Medical Association endorsed Bayer Heroin for kids, touting its ability to ease coughs. Heroin definitely eases coughs. And so does smoking meth! In offering this endorsement, the AMA apparently borrowed some of the FDA’s screwy logic, which claims “The benefits outweigh the risks.”
This means, of course, that the benefits to the drug companies outweigh the risks to the children!
During all this, of course, the AMA utterly failed to inform parents that heroin was a highly addictive narcotic drug. So parents were dosing their babies with heroin — all with the full approval of the American Medical Association!
Today, the FDA spearheads the promotion of drugs to children, doing its best to promote toxic synthetic chemicals that artificially alter brain chemistry while outlawing any mention of natural remedies that work much better (like omega-3 oils, which are natural brain chemistry stabilizers). The FDA also utterly fails to ban toxic chemical food ingredients known to destroy healthy brain chemistry (like MSG and artificial food coloring).
Thus, in one hundred and ten years, western medicine has learned nothing! It still poisons the children with the full approval of “health authorities” all while enriching the powerful drug companies.
Big Pharma’s ties to Nazi Germany
In remembering the endorsement by the AMA of heroin treatments for children, it’s helpful to consider a bit more of the history of Big Pharma:
The name Heroin comes from the German word heroisch, which means “heroic.” Take enough heroin, and you might feel heroic, too. (At least until the high is gone.)
Bayer, of course, is a German pharmaceutical company with all sorts of interesting ties to Nazi Germany and the medical experiments conducted on Jewish prisoners during World War II. In 1956, for example, Fritz ter Meer became the chairman of Bayer. What’s so interesting about that? This was after he served seven years in prison for carrying out experiments on Jewish prisoners at Auschwitz.
One minute you’re committing crimes against humanity, and the next minute you’re the Chairman of Bayer. Amazing, isn’t it? (Amazing how deep the criminal backgrounds go for these Big Pharma people, it seems…)
More recently, Bayer has been found contaminating the U.S. rice crop with genetically engineered rice seeds.
There’s a lot more you probably didn’t know about the true history of Big Pharma’s dangerous experiments on humans.
Pushing narcotics for children – the Big Pharma way!
Bayer eventually pulled its heroin from the market in 1910, by the way. In 1914, the U.S. Congress passed the Harrison Narcotics Tax Act, which allowed heroin to continue to be prescribed as a medicine. In wasn’t until 1924 that the U.S. Congress banned heroin sales outright.
Interestingly, 85 years later, narcotics are routinely prescribed to U.S. schoolchildren as “ADHD medications” (they are actually amphetamine drugs). And now, with the help of the FDA, drugs like Seroquel and Zyprexa can be legally prescribed to children by doctors.
And yet even that is just a hodge-podge of FDA theater, because in reality, doctors have been illegally prescribing these drugs to children for well over a decade, and not one doctor has ever been arrested or fined for engaging in this “off-label prescribing” of dangerous, mind-altering chemicals. In fact, the FDA’s decision today isn’t really about medical science at all: It’s about sweeping under the rug the routine crimes of America‘s psychiatrists who have been poisoning children’s minds with dangerous drugs for years on end.
And rather than enforcing existing medical laws that forbid off-label prescribing of drugs, the FDA apparently finds it more convenient to simply legalize the criminal behavior of psychiatrists via a politically-motivated vote.
A hundred and ten years from now, this decision will be viewed with the same disbelief that we now evoke when looking back at the AMA’s endorsement of heroin cough syrup for children. Future citizens of our world will look back and ask themselves, “Were these people on drugs?”
And the answer, of course, is yes, the decision makers are all on drugs. They’re taking drugs, pushing drugs and profiting from drugs. And now they’re going after the children with those same drugs because there’s more profit to be found by expanding the age range of victims who can be targeted for financial exploitation by the pharmaceutical industry. Children are simply the next target on the corporate profits priority list.
Let’s be honest here: These are crimes against our children. And those FDA advisory panel members who voted to whitewash these crimes are, themselves, guilty of crimes against humanity (and should be arrested and tried accordingly).
The Nazis gassed Jewish children with Zyklon B. America now openly drugs its own children with Zyprexa.
Both chemicals, not coincidentally, were invented and manufactured by the same industry: The pharmaceutical industry.